INC Research Announces 2013 "Perspectives" Webinar Series
(Thomson Reuters ONE) -
Series Offers Industry-Leading Insights into Key Issues in Clinical Development
Raleigh, N.C., May 15, 2013 - INC Research, LLC, a therapeutically focused
global clinical research organization (CRO) with a Trusted Process(®) for
delivering reliable results, today announced it will kick off its 2013
"Perspectives" webinar series June 18 with a session focused on clinical
innovation. Designed to provide the latest insights on clinical research, the
eight-session series will feature industry experts and INC Research thought
leaders offering valuable insights and practical knowledge on a range of topics,
including strategic data monitoring, site relationships and more.
"We're delighted to be continuing our Perspectives series with a host of new
topics that examine key R&D issues," said Alistair Macdonald, Chief Operating
Officer. "The interactive format of our webinars gives attendees the opportunity
to gain valuable insight from top industry executives about the issues affecting
them most along with real-world guidance they can apply to their clinical
development efforts."
INC's June 18 session focuses on how innovative approaches to the R&D process
are shaping the future of clinical research, and will be followed by two
sessions in September on product lifecycle management and reducing site
monitoring costs using a strategic approach. The Perspectives series also
includes three sessions with a strong therapeutic and patient focus, including
"Pediatric safety monitoring: Role of IRBs and DSMBs," "Pediatric patient/parent
recruitment for rare disease indications" and "Recent results from large
randomized trials in cardiovascular disease and implications for clinical
practice." The 2013 Perspectives series concludes with a session in November
exploring the complexities, challenges and best practices of conducting global
clinical trials, and a session in early December sharing insights on the
site/sponsor/CRO relationship dynamic and how companies are making these
relationships more efficient and effective.
To view the full "Perspectives" schedule, register for the upcoming sessions,
access the 2012 "Perspectives" archive or submit a topic for a future session,
visit www.incresearch.com/perspectives.
About INC Research
INC Research is a therapeutically focused clinical research organization with a
high-performance reputation for conducting global clinical development programs
of the highest integrity. Pharmaceutical and biotechnology companies look to INC
Research for a complete range of customized Phase I through Phase IV programs in
all therapeutic areas and innovative pediatric and women's health trials. The
company's Trusted Process(®) methodology and therapeutic foresight lead
customers to more confident, better-informed drug and device development
decisions. INC Research is headquartered in Raleigh, NC. For more information,
please visit www.incresearch.com or follow us at (at)inc_research.
Contact: Lori Dorer, Media +1 (513) 345-1685
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
[HUG#1702343]
Unternehmensinformation / Kurzprofil:
Datum: 15.05.2013 - 19:30 Uhr
Sprache: Deutsch
News-ID 260507
Anzahl Zeichen: 3851
contact information:
Town:
Raleigh
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 234 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"INC Research Announces 2013 "Perspectives" Webinar Series"
steht unter der journalistisch-redaktionellen Verantwortung von
INC RESEARCH, LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
